NCT03146416View on ClinicalTrials.gov

Study of Evinacumab (REGN1500) in Caucasian and in Japanese Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

May 16, 2017

Primary Completion Date

June 14, 2018

Study Completion Date

June 14, 2018

Conditions
Healthy Volunteers
Interventions
DRUG

Evinacumab

SC or IV administration of Evinacumab

DRUG

Placebo

Matching placebo

Trial Locations (1)

90630

WCCT Global, Inc., Cypress

All Listed Sponsors
lead

Regeneron Pharmaceuticals

INDUSTRY

NCT03146416 - Study of Evinacumab (REGN1500) in Caucasian and in Japanese Healthy Volunteers | Biotech Hunter | Biotech Hunter